Registration Dossier

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study For read-across justification refer to section 13.

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
according to guideline
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
yes (incl. QA statement)
BASF AG, Experimental Toxicology and Ecology
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
Disodium dihydrogen ethylenediaminetetraacetate
EC Number:
EC Name:
Disodium dihydrogen ethylenediaminetetraacetate
Cas Number:
disodium dihydrogen 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
Details on test material:
- Name of test material (as cited in study report): Trilon BD
- Purity: 90.1 %
- Purity test date: 31.Oct 1996
- Batch No.: 31-9412
- Storage condition of test material: room temperature
- Stability under test conditions: The stability of the test substance at room temperature in the vehicle water over a period of 4 hours has been verified analytically

Test animals

Details on test animals or test system and environmental conditions:
- Source: Charles River Deutschland GmbH
- Weight at study initiation: Mean 29 g
- Housing: Makrolon cages type Mill, in groups of 5
- Diet: Kliba, standardized pelleted feed, Provimi Kliba SA, Kaiseraugst, Switzerland, ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days

- Temperature (°C): 20 - 24"C
- Humidity (%): 30 - 70% .
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
- Vehicle used: water
- Concentration of test material in vehicle:
- Amount of vehicle (if gavage or dermal):
- Type and concentration of dispersant aid (if powder):
- Lot/batch no. (if required):
- Purity:
Details on exposure:
- The low dose group was given 500 mg test substance/kg body weight or 20 ml/kg body weight of a solution with a concentration of 2.5 g/100 ml.
- The intermediate dose group was given 1,000 mg test substance/kg body weight or 20 ml/kg body weight of a solution with a concentration of 5.0 g/100 ml.
- The top dose group was given 2,000 mg test substance/kg body weight or 20 ml/kg body weight of a solution with a concentration of 10.0 g/100 ml.
Duration of treatment / exposure:
48 h (animals were treated twice at 24 h intervals)
Frequency of treatment:
Doses / concentrations
Doses / Concentrations:
500; 1000; 2000 mg/kg bw
actual ingested
No. of animals per sex per dose:
Control animals:
yes, concurrent vehicle
Positive control(s):
20 mg of cyclophosphamide (CPP)/kg body weight or 0 .15 mg of vincristine sulphate (VCR)/kg body weight, both, dissolved in purified water, were administered to male animals once, orally each in a volume of 10 ml/kg body weight.


Tissues and cell types examined:
bone marrow
Details of tissue and slide preparation:

2,000 polychromatic erythrocytes (PCE) from each of the male animals of every test group are evaluated and investigated for micronuclei (MN). The normochromatic erythrocytes (NCE) which occur are also scored. The following parameters have been evaluated:
- Number of polychromatic erythrocytes
- Number of polychromatic erythrocytes containing micronuclei
- Number of normochromatic erythrocytes
- Number of normochromatic erythrocytes containing micronuclei
- Ratio of polychromatic to normochromatic erythrocytes
- Number of small micronuclei (d < D/4) and of large micronuclei (d > D/4) (d = diameter of micronucleus, D = cell diameter )
Evaluation criteria:
The test chemical is to be considered positive in this assay if the following criteria are met:
- A dose-related and significant increase in the number of micronucleated polychromatic erythrocytes was observed .
- The proportion of cells containing micronuclei exceeded both the values of the concurrent negative control range and the negative historical control range .

A test substance is generally considered negative in this test system if:
- There was no significant increase in the number of micronucleated polychromatic erythrocytes at any dose above concurrent control frequencies.
- The frequencies of cells containing micronuclei were within the historical control range.
The statistical evaluation of the data was carried out using the program system MUKERN. A comparison of the dose group with the vehicle control was carried out using the Wilcoxon test for the hypothesis of equal medians.

Results and discussion

Test results
no effects
As clinical signs only piloerrection were observed
Vehicle controls validity:
Negative controls validity:
not applicable
Positive controls validity:
Additional information on results:
- After two administrations of the highest dose of 2,000 mg/kg body weight, 0.4%o polychromatic erythrocytes containing micronuclei were found after 24 hours.
- In the two lower dose groups, rates of micronuclei of about 0.6%o (1,000 mg/kg group) and 0.7%o (500 mg/kg group) were detected.
- With 12.7%o the positive control substance cyclophosphamide for clastogenicity led to the expected increase in the number of polychromatic erythrocytes containing exclusively small micronuclei at a dose level of 20 mg/kg body weight.
- With 81 .7%o the positive control vincristine for induction of spindle poison effects also led to a clearly enhanced number of polychromatic erythrocytes containing micronuclei with the expected amount of large micronuclei, i .e. 10.5%o.
- The number of normochromatic erythrocytes containing micronuclei did not differ to any appreciable extent in the negative control or in the various dose groups

Thus, the test substance Trilon BD did not lead to any increase in the rate of micronuclei. The number of normochromatic or polychromatic erythrocytes containing small micronuclei (d < D/4) did not deviate from the vehicle control value and was within the historical control range. Nor were large micronuclei (d > D/4) observed either in the negative control group or in the three dose groups of Trilon BD.

No inhibition of erythropoiesis, induced by the treatment of mice with Trilon BD was detected; the ratio of polychromatic to normochromatic erythrocytes was always in the same range as that of the control values in all dose groups.

Applicant's summary and conclusion

Interpretation of results (migrated information): negative